The willingness is there
In March 2026, The Harris Poll surveyed 503 U.S. primary care physicians for Patient Advocate Foundation. 86% said they are likely to refer a patient to a clinical trial, and 98% view clinical trials positively. 37% said they have ever referred a patient.
Patients point the same way
In CISCRP's 2025 Perceptions & Insights Study, 51% of respondents said they would prefer to learn about a study from their own doctor. Among 4,415 trial participants, 16% first heard about their trial from a physician, behind online sources at 22% and research center staff at 18%. In 2017, physicians led that list at 19%.
What it means for study planning
Both sides want the first conversation about a trial to happen inside care. A useful feasibility question for 2027 protocols is where patients will first hear about the study, and from whom.
Where Hawthorne Health fits
Hawthorne Health runs research inside community pharmacies, so the first conversation about a study can happen during care patients already receive, with pharmacy staff they already know. In a post-approval REMS imaging program we support, 53% of prescribers referred more than one patient (351 of 664, January to November 2025).